首页> Annals of the New York Academy of Sciences> Vaccine innovations for emerging infectious diseases-a symposium report.

Vaccine innovations for emerging infectious diseases-a symposium report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jennifer,Cable

第一单位： Science Writer, New York, New York.

作者： Jennifer,Cable ^[1] ; Padmini,Srikantiah ^[2] ; James E,Crowe ^[3] ; Bali,Pulendran ^[4] ; Adrian,Hill ^[5] ; Ann,Ginsberg ^[6] ; Wayne,Koff ^[7] ; Anuja,Mathew ^[8] ; Tony,Ng ^[9] ; Kathrin,Jansen ^[10] ; Gregory,Glenn ^[11] ; Sallie,Permar ^[12] ; Ian,Wilson ^[13] ; David B,Weiner ^[14] ; Drew,Weissman ^[15] ; Rino,Rappuoli ^[16]

作者单位： Science Writer, New York, New York. ^[1] Bill & Melinda Gates Foundation, Seattle, Washington. ^[2] Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center; and Vanderbilt University, Nashville, Tennessee. ^[3] Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University, Stanford, California. ^[4] The Jenner Institute, University of Oxford, Oxford, United Kingdom. ^[5] International AIDS Vaccine Initiative, New York, New York. ^[6] The Human Vaccines Project, New York, New York. ^[7] Department of Cell and Molecular Biology, The University of Rhode Island, Kingston, Rhode Island. ^[8] Department of Microbiology & Immunology, Albert Einstein College of Medicine, New York, New York. ^[9] Pfizer, New York, New York. ^[10] Novavax, Rockville, Maryland. ^[11] Duke University, Durham, North Carolina. ^[12] Department of Integrative Structural and Computational Biology, The Scripps Research Institute, San Diego, California. ^[13] Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania. ^[14] Department of Medicine, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania. ^[15] GlaxoSmithKline, Brentford, United Kingdom. ^[16]